New Releases from NCBI BookshelfEnzalutamide for hormone-relapsed non-metastatic prostate cancer.​Enzalutamide for hormone-relapsed non-metastatic prostate cancer.

Post Content

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top